Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers
出版年份 2013 全文链接
标题
Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers
作者
关键词
Lung cancer, Biomarkers, EGFR, ALK
出版物
Clinical & Translational Oncology
Volume 15, Issue 7, Pages 503-508
出版商
Springer Nature
发表日期
2013-01-28
DOI
10.1007/s12094-012-0983-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tissue-Sparing Application of the Newly Proposed IASLC/ATS/ERS Classification of Adenocarcinoma of the Lung Shows Practical Diagnostic and Prognostic Impact
- (2012) William Sterlacci et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- A Study of ΔNp63 Expression in Lung Non-Small Cell Carcinomas
- (2012) Daisuke Nonaka AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Comparison of Reverse Transcription-Polymerase Chain Reaction, Immunohistochemistry, and Fluorescence In Situ Hybridization Methodologies for Detection of Echinoderm Microtubule-Associated Proteinlike 4–Anaplastic Lymphoma Kinase Fusion–Positive Non–Small Cell Lung Carcinoma: Implications for Optimal Clinical Testing
- (2012) Michelle L. Wallander et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
- (2012) A J Atherly et al. BRITISH JOURNAL OF CANCER
- Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP)
- (2012) Pilar Garrido et al. Clinical & Translational Oncology
- New Strategies in Squamous Cell Carcinoma of the Lung: Identification of Tumor Drivers to Personalize Therapy
- (2012) K. A. Gold et al. CLINICAL CANCER RESEARCH
- Mechanisms of Resistance to Crizotinib in Patients withALKGene Rearranged Non–Small Cell Lung Cancer
- (2012) Robert C. Doebele et al. CLINICAL CANCER RESEARCH
- Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 (HER2) Tyrosine Kinase Mutations in Lung Adenocarcinomas
- (2012) M. E. Arcila et al. CLINICAL CANCER RESEARCH
- Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations
- (2012) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- Discordance between anaplastic lymphoma kinase status in primary non-small-cell lung cancers and their corresponding metastases
- (2012) Hyojin Kim et al. HISTOPATHOLOGY
- Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies
- (2012) Arne Warth et al. HISTOPATHOLOGY
- TheALKtranslocation in advanced non-small-cell lung carcinomas: preapproval testing experience at a single cancer centre
- (2012) Esther Conde et al. HISTOPATHOLOGY
- KRASWild-Type Lung Cancer: A Moving Target in an Era of Genotype Migration
- (2012) Geoffrey R. Oxnard et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 Mutations in Non–Small-Cell Lung Cancer Can Be Continually Targeted
- (2012) Ronan J. Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib
- (2012) Oliver Gautschi et al. Journal of Thoracic Oncology
- Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas
- (2012) William D Travis MODERN PATHOLOGY
- RET, ROS1 and ALK fusions in lung cancer
- (2012) Kengo Takeuchi et al. NATURE MEDICINE
- EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas
- (2012) Z.-Y. Chen et al. ONCOLOGIST
- Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation
- (2012) Matthew D. Wilkerson et al. PLoS One
- A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry
- (2012) Bárbara Angulo et al. PLoS One
- EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations
- (2012) Erik Thunnissen et al. VIRCHOWS ARCHIV
- Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas
- (2011) Akihiko Yoshida et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Lung Carcinoma Morphology or Mutational Profile: That Is the Question
- (2011) Sanja Dacic ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Personalized medicine for lung cancer: new challenges for pathology
- (2011) Keith M Kerr HISTOPATHOLOGY
- Clinical Characteristics of Patients With Lung Adenocarcinomas HarboringBRAFMutations
- (2011) Paul K. Paik et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunhistochemistry by Means of Widely Agreed-Upon Markers (Cytokeratins 5/6 and 7, p63, Thyroid Transcription Factor-1, and Vimentin) on Small Biopsies of Non-small Cell Lung Cancer Effectively Parallels the Corresponding Profiling and Eventual Diagnoses on Surgical Specimens
- (2011) Giuseppe Pelosi et al. Journal of Thoracic Oncology
- Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification
- (2011) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material Approach
- (2011) Giuseppe Pelosi et al. Journal of Thoracic Oncology
- The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group
- (2011) Erik Thunnissen et al. LUNG CANCER
- p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma
- (2011) Justin A Bishop et al. MODERN PATHOLOGY
- PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors
- (2011) F. Janku et al. MOLECULAR CANCER THERAPEUTICS
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- (2011) Peter S. Hammerman et al. Cancer Discovery
- Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples
- (2010) Jefferson Terry et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens
- (2010) Sanjay Mukhopadhyay et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Tissue Is the Issue: Personalized Medicine for Non-Small Cell Lung Cancer
- (2010) F. R. Hirsch et al. CLINICAL CANCER RESEARCH
- The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer
- (2010) Corey J. Langer et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy Differences of Pemetrexed by Histology in Pretreated Patients with Stage IIIB/IV Non-small Cell Lung Cancer: Review of Results from an Open-Label Randomized Phase II Study
- (2010) Kaoru Kubota et al. Journal of Thoracic Oncology
- Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop
- (2010) Robert Pirker et al. Journal of Thoracic Oncology
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung
- (2010) Esther Conde et al. PLoS One
- Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
- (2010) J. Weiss et al. Science Translational Medicine
- Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM Classification based on recommendations of the IASLC Staging Committee
- (2009) William D Travis HISTOPATHOLOGY
- Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung
- (2009) Valentina Monica et al. MODERN PATHOLOGY
- Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis
- (2008) Noriko Motoi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Histopathology of BRAF-V600E–mutated Lung Adenocarcinoma
- (2008) Samuel A. Yousem et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non–Small-Cell Lung Cancer Working Group: Standardization for Use in the Clinical Trial Setting
- (2008) David A. Eberhard et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Lung Cancer Symptom Scale Outcomes in Relation to Standard Efficacy Measures: An Analysis of the Phase III Study of Pemetrexed Versus Docetaxel in Advanced Non-small Cell Lung Cancer
- (2008) Filippo de Marinis et al. Journal of Thoracic Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now